[Transdermal treatment using the betablocker mepindolol].
D000279:Administration, Cutaneous; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000818:Animals; D006801:Humans; D010869:Pindolol / Q000008:administration & dosage / Q000031:analogs & derivatives*
D000319:Adrenergic beta-Antagonists; C015340:mepindolol; D010869:Pindolol
Transdermaltherapie mit dem Betablocker Mepindolol.